2024 Annual Meeting | C46 - Child Neurology: Neuro-oncology
| 01:00 PM - 01:40 PM MDT | Speaker |
Pediatric CNS Tumor Review and Updates
Sonia Partap, MD, FAAN, Nicole Ullrich, MD, PhD, MMSci, FAAN |
| 01:40 PM - 02:20 PM MDT | Speaker |
Molecular Therapies in Neurocutaneous Syndromes and Low-grade Glioma
Yasmin Khakoo, MD, FCNS, FAAN, FAAP, FAAN |
| 02:20 PM - 03:00 PM MDT | Speaker |
Neurologic Toxicity in Survivors of Childhood Brain Tumors
Nicole Ullrich, MD, PhD, MMSci, FAAN |
| Sonia Partap, MD, FAAN | The institution of Dr. Partap has received research support from NIH. |
| Nicole Ullrich, MD, PhD, MMSci, FAAN | Dr. Ullrich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. The institution of Dr. Ullrich has received research support from Children's Tumor Foundation. Dr. Ullrich has received intellectual property interests from a discovery or technology relating to health care. Dr. Ullrich has received publishing royalties from a publication relating to health care. |
| Yasmin Khakoo, MD, FCNS, FAAN, FAAP, FAAN | Dr. Khakoo has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Khakoo has a non-compensated relationship as a President with Child Neurology Society that is relevant to AAN interests or activities. |